Current Report Filing (8-k)
2022年2月15日 - 10:31PM
Edgar (US Regulatory)
0001760903
false
0001760903
2022-02-15
2022-02-15
0001760903
us-gaap:CommonStockMember
2022-02-15
2022-02-15
0001760903
JUPW:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember
2022-02-15
2022-02-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C., 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 15, 2022
JUPITER
WELLNESS, INC.
(Exact
name of registrant as specified in charter)
Delaware
|
|
001-39569
|
|
83-2455880
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1061
E. Indiantown Rd., Ste. 110, Jupiter, FL 33477
(Address
of principal executive offices) (Zip Code)
(561)
462-2700
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which
registered
|
Common
Stock
|
|
JUPW
|
|
The
Nasdaq Stock Market LLC
(The
Nasdaq Capital Market)
|
|
|
|
|
|
Warrants,
each exercisable for one share of Common Stock at $8.50 per share
|
|
JUPWW
|
|
The
Nasdaq Stock Market LLC
(The
Nasdaq Capital Market)
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
8.01 Other Events.
On
February 15, 2022, Jupiter Wellness, Inc. (the “Company”) issued a press release announcing that its merger partner
Next Frontier Pharmaceuticals’ Executive Chairman Shannon Soqui was interviewed on Benzinga’s All Access 6 Emerging Growth
Companies To Watch In 2022. A copy of this press release is attached as Exhibit 99.1
Item
9.01 Financial Statements and Exhibits
Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
February 15, 2022
|
JUPITER
WELLNESS, INC.
|
|
|
|
By:
|
/s/
Brian John
|
|
|
Brian
John
|
|
|
Chief
Executive Officer
|
Jupiter Wellness (NASDAQ:JUPW)
過去 株価チャート
から 6 2024 まで 7 2024
Jupiter Wellness (NASDAQ:JUPW)
過去 株価チャート
から 7 2023 まで 7 2024